Form 4 for TECH Bio-Techne
Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-24 · accession 0001062993-23-017156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-28 | 2023-08-24 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $47.60 | +2,100 | 21.2K | +11% | +$100.0K |
| D | 2023-08-28 | 2023-08-24 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | -2,100 | 109.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | M | A | 2,100 | $47.60 | 21,225 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-08-24 | M | D | 2,100 | $0.00 | 109,536 | D | $47.60 · — to 2026-08-07 | 2,100 Common Stock | (F1) Fully exercisable. |